LifeArc supports the GenOMICC COVID-19 Study

Medical research charity, LifeArc, announces today that it is providing £5 million funding to support the work of the GenOMICC COVID-19 Study, led by the GenOMICC consortium in partnership with Genomics England. The study, launched in May 2020, is using genomics to investigate why some people are affected more severely…

Epilim IV

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. EPILIM® IV Sodium Valproate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Epilim IV. It does not contain all of the available information. It does not take the place of…

What is Polymyalgia Rheumatica?

Polymyalgia rheumatica (PMR) is a rheumatic disease characterized by recurrent inflammatory episodes. PMR is usually seen in Caucasians living in Northern Europe and North America. The condition generally affects people over the age of 50 years (with average patient age being above 70 years), and is more common in women…

Genotropin MiniQuick

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. GENOTROPIN MINIQUICK® somatropin (rbe), recombinant human growth hormone Consumer Medicine Information What is in this leaflet This leaflet answers some of the common questions that you may have about GENOTROPIN MiniQuick. It does not contain all the…

Research identifies genetic risk factor for stroke

A team of Geisinger researchers has identified a common genetic variant as a risk factor for stroke, especially in patients older than 65. Cerebral small vessel disease (SVD) causes about a quarter of ischemic strokes worldwide and is the most common cause of vascular dementia. SVD can manifest as lesions…